KRMN

KRMN - Karman Holdings Inc

SPECULATIVE BUYAWAIT ENTRYIndustrials - Aerospace & Defense2026-08-09Data 34 days oldUSD 58.23

Conviction

out of 100

Executive Summary

Karman Holdings Inc is a US-domiciled aerospace and defence business that designs and manufactures integrated mission-critical systems for space and defence customers, including components, subsystems and integrated delivery programmes. The company operates within the Industrials sector, Aerospace & Defence industry, with a market position that is described in public sources as a focused mid-tier supplier to prime contractors and government end-users.

The investment case rests on management's raised 2026 guidance (revenue of USD715m - USD730m and adjusted EBITDA of USD207m - USD218m, as reported in early-2026 earnings materials), continued capacity expansion, and incremental M&A activity. The key near-term catalyst is the second-quarter FY26 earnings release, with the underlying 8-K for the quarter filed on 6 August 2026. The primary risk is that Karman must deliver complex integrated systems at scale on cost and schedule, with a customer mix skewed toward government programmes that are exposed to US defence-budget volatility.

SPECULATIVE BUY. Conviction Score: 45/100. The view would shift toward a higher-conviction buy on a meaningful pullback that reduces the elevated trailing P/E, on a named contract win or OEM integration announcement, or on confirmation that capacity additions are converting into on-time, on-margin deliveries; it would shift to a Hold or Sell on a guidance reset, programme delay, or a sharp deterioration in defence-spending outlook.

Wait for entry. Current price USD 58.23 is 10.6% above the buy ceiling of USD 52.67. New positions only below the ceiling.

AWAIT ENTRYSPECULATIVE BUY · 45/100Now USD 58.23 · buy ≤ USD 52.67 · trim ≥ USD 70.00

Thesis break: The thesis would be invalidated by a cut to 2026 revenue or adjusted EBITDA guidance below the original pre-raise ranges, a named prime-contract loss, a fixed-price programme cost overrun large enough to impair segment margins, or a dilutive equity issuance to fund M&A.

Business Model

Karman generates revenue through the design, manufacture and integration of mission-critical hardware for space and defence applications. The product set spans components, subsystems and integrated systems delivered to prime contractors, OEMs and direct US government end-users. Public reporting on FY25 results describes record revenue of approximately USD466m (calculated from the disclosed 37% year-on-year growth from a comparable prior-year base) and adjusted EBITDA growth of 37% year-on-year, with management indicating that the 2026 revenue range of USD715m - USD730m represents roughly 53% growth driven by organic demand, capacity expansion and acquisitions.

Customer mix is heavily weighted toward US defence and space end-markets, with revenue tied to multi-year programme deliveries, government contracts and integration work packages subcontracted from larger primes. The reporting currency is USD. Margins are governed by the mix between higher-margin subsystem and integration work and lower-margin hardware production, and by the absorption of fixed costs as new capacity comes online through 2026.

The competitive moat, insofar as one is evident from public sources, rests on qualification status on funded defence and space programmes, integrated-delivery capability (rather than component-only supply), and incumbency on existing programme lines of supply. The research data does not name any specific OEM integrations, sole-source contracts or proprietary technology differentiators, so the durability of the moat should be treated as unconfirmed beyond qualification and programme incumbency.

Financial Snapshot

Price

USD 58.23

Market Cap

USD 7.7bn

P/E Ratio

257.3x

52w High

USD 118.38

52w Low

USD 43.68

Distance from 52wH

-50.8%

Avg Volume

3588565

Currency

USD

Recent Catalysts

[2026-08-06] - Karman filed a Form 8-K with the SEC reporting its second-quarter FY26 results, accompanied by an earnings press release exhibit referencing "Second Quarter Fiscal Year 2026" performance. Source: SEC EDGAR (Form 8-K filed 6 August 2026, with EX-99.1 press release).

[2026-05-12] - Karman was scheduled to report its Q1 FY26 results on 12 May 2026, as referenced on ChartMill's company profile page. Source: ChartMill company profile.

[2026-05-04] - Vanguard Group Inc. disclosed that it had acquired additional shares in Karman Holdings Inc, indicating incremental institutional accumulation around the Q1 reporting window. Source: Daily Political (filing/ownership disclosure reference dated 4 May 2026).

[2026-05-05] - Karman shares traded down 6.7% intraday, with the stock touching a session low around USD61.01, reflecting a sharp negative session reaction despite prior-period fundamentals. Source: Daily Political price-move note dated 5 May 2026.

[Early 2026 guidance update] - Karman raised 2026 revenue guidance to USD715m - USD730m and adjusted EBITDA guidance to USD207m - USD218m, citing strong demand, capacity expansion and M&A, alongside record Q4 and FY25 results with revenue up 37% and adjusted EBITDA up 37% year-on-year. Source: StockAnalysis.com summary of company-issued guidance materials.

Thesis Evaluation

Bull Case (10% weight)

Karman converts its raised 2026 guidance into reported revenue and adjusted EBITDA at or above the top end of the USD715m - USD730m / USD207m - USD218m ranges, capacity additions ramp without margin disruption, and announced M&A accretes within the first two to three quarters of ownership. A named prime-contractor integration or sole-source award would reinforce the bull thesis over the next 12 months. Bull-case 12-month target: $95.

Base Case (50% weight)

Karman delivers 2026 results broadly within the guided ranges, M&A contribution is modest, capacity additions add revenue but compress near-term margins as fixed costs are absorbed, and the stock re-rates modestly off depressed levels while still trading at a premium earnings multiple. Base-case 12-month target: $70.

Bear Case (40% weight)

Programme-level delays, fixed-price cost overruns on integrated-system deliveries, or US defence-budget volatility weigh on bookings and margins; M&A integration absorbs cash and management attention; and the trailing P/E of 257.3, as cited in the research inputs, compresses as growth disappoints. Bear-case 12-month target: $44.

Weighted conviction:Bull (10%) x 100 + Base (50%) x 62 + Bear (40%) x 10 = 45/100. SPECULATIVE BUY.

Key Risks

Extreme valuation multiple: Public commentary and research inputs flag a trailing P/E in the region of 257x, leaving little margin for execution slippage relative to current consensus. Estimated probability: 70%. Impact: severe.
Integrated-system delivery execution: SEC filing risk-factor language highlights the requirement to deliver complex integrated systems at scale, with cost and schedule risk concentrated on fixed-price and development work. Estimated probability: 55%. Impact: severe.
Government contract concentration: Revenue mix is heavily weighted toward US defence and space end-customers, exposing the top line to budget continuing-resolution dynamics, programme cancellations and procurement-cycle volatility. Estimated probability: 45%. Impact: severe.
M&A integration and dilution: Management has flagged acquisitions as a driver of the raised 2026 guidance, and any integration shortfall, goodwill impairment or dilutive equity raise would weigh on per-share metrics. Estimated probability: 40%. Impact: moderate.
Capacity-expansion execution: The 53% guided revenue growth requires new capacity to come online on schedule; ramp inefficiencies could compress adjusted EBITDA margins relative to the USD207m - USD218m guide. Estimated probability: 50%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: investors with a higher-risk tolerance, a multi-year (minimum 18 - 24 month) holding horizon, and a willingness to underwrite defence-budget, programme-execution and valuation risk in pursuit of growth; size KRMN as a satellite position within a broader industrials or defence allocation rather than a core holding.

Avoid if: you require near-term cash flow visibility, are valuation-sensitive on a P/E basis, cannot tolerate sharp drawdowns in the 30 - 50% range that are common in small-to-mid-cap defence suppliers around budget cycles, or have a policy or mandate constraint that limits exposure to US government contracting risk.

Recommendation

SPECULATIVE BUY - 45/100. This tier reflects a constructive but unconfirmed fundamental setup, with raised 2026 guidance, capacity expansion and M&A optionality offset by an extreme trailing P/E and execution risk on integrated-system deliveries. An upgrade to a higher-conviction Buy would require a meaningful multiple compression accompanied by confirmed in-line or better execution against guidance and a visible, named contract or OEM-integration win. A downgrade to Hold or Sell would be triggered by a guidance reset, a programme-level delay or cost overrun on an integrated delivery, evidence of defence-budget deterioration, or a dilutive capital raise tied to M&A. At the current price of $58.23 the shares trade above our buy ceiling of $52.67: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $62.10, 7% above the current price of $58.23 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $52.67 - below this level the upside to the base-case target ($70.00) is at least 2x the downside to the bear case ($44.00), the minimum risk/reward we require before committing new capital.

HOLD

between $52.67 and $70.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $70.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 10%.

SELL

if the thesis would be invalidated by a cut to 2026 revenue or adjusted EBITDA guidance below the original pre-raise ranges, a named prime-contract loss, a fixed-price programme cost overrun large enough to impair segment margins, or a dilutive equity issuance to fund M&A, regardless of price - the bear target of $44.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 45/100. Trend versus prior report: Down.

CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)

Report date	Conviction
2026-08-09	45
2026-07-25	51
2026-06-28	51
2026-05-30	51
2026-04-27	79

See the trade-card view →

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow drawn from financial-news wires and aggregators (Yahoo Finance, Finviz, ChartMill, StockAnalysis.com), regulatory filings (SEC EDGAR 8-K dated 6 August 2026 and related EX-99.1 press release), institutional-ownership disclosures as reported in third-party news outlets, and earnings-day price-move commentary in the financial press. Analyst and aggregator commentary (including Simply Wall St and Seeking Alpha earnings-call summaries) was used for background colour only and is not cited as the source for any factual claim.

Primary source types: SEC filings (Form 8-K and associated exhibits), company-issued earnings press releases and guidance statements, company investor relations materials referenced via StockAnalysis.com, third-party research aggregating primary disclosures, and public exchange-level pricing data via Yahoo Finance and Finviz.

Key sources

Data correct as of 2026-08-09